Background: Type II diabetes mellitus (DM) is a risk factor for urinary stones, but the pathogenesis remains unclear. The aim of our study was to present the distribution of stone components between DM and no DM group from a local stone center in China and to help the prevention department in decision-making. Methods: We reviewed the records of patients with upper urinary stones attending our hospital from January 2015 to September 2018. The patients with complete information were divided into 2 groups: type II DM group (DM group) and without DM group (no DM group). The distribution of stone components was analyzed. Results: Two hundred twenty-two patients were complicated with DM, whereas 1,894 (89%) were not. Significant difference was found in the distribution of hypertension and BMI (p = 0, p = 0, respectively). Distribution of sex, age, and stone components did not differ between the 2 groups. By the binary logistic analysis, increasing age and sex seemed to be the main risk factors influencing the stone components. Only the calcium stone seemed to be free of the -impact from age and sex. Occurrence of hypertension is a single risk factor for calcium stone from our analysis. Presence of diabetes and increasing BMI was not found to be significantly associated with the risk for any stone component. Conclusions: In a local district, DM might not be the main factor associated with an increased risk for uric acid stone formation or any stone component. We should also consider the local characteristics of the stone distribution.

1.
Lieske
,
JC
,
de la Vega
LS
,
Gettman
MT
,
Slezak
JM
,
Bergstralh
EJ
,
Melton
LJ
, et al.
Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study
.
Am J Kidney Dis
.
2006
:
48
(
6
):
897
904
.
2.
Meydan
,
N
,
Barutca
S
,
Caliskan
S
,
Camsari
T
.
Urinary stone disease in diabetes mellitus
.
Scand J Urol Nephrol
.
2003
;
37
(
1
):
64
70
.
3.
Daudon
,
M
,
Traxer
O
,
Conort
P
,
Lacour
B
,
Jungers
P
.
Type 2 diabetes increases the risk for uric acid stones
.
J Am Soc Nephrol
.
2006
;
17
(
7
):
2026
33
.
4.
Hartman
,
C
,
Friedlander
JI
,
Moreira
DM
,
Elsamra
SE
,
Smith
AD
,
Okeke
Z
.
Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus
.
BJU Int
.
2015
;
115
(
4
):
619
24
.
5.
Liu
,
LH
,
Kang
R
,
He
J
,
Zhao
SK
,
Li
FT
,
Zhao
ZG
.
Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies
.
Urolithiasis
.
2015
;
43
(
4
):
293
301
.
6.
Weinberg
,
AE
,
Patel
CJ
,
Chertow
GM
,
Leppert
JT
.
Diabetic severity and risk of kidney stone disease
.
Eur Urol
.
2014
;
65
(
1
):
242
7
.
7.
Bell
,
DS
.
Beware the low urine pH: the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes
.
Diabetes Obes Metab
.
2012
;
14
(
4
):
299
303
.
8.
Nerli
R
,
Jali
M
,
Guntaka
AK
,
Patne
P
,
Patil
S
,
Hiremath
MB
.
Type 2 diabetes mellitus and renal stones
.
Adv Biomed Res
.
2015
;
4
:
180
.
9.
Grant
,
C
,
Guzman
G
,
Stainback
RP
,
Amdur
RL
,
Mufarrij
P
.
Variation in kidney stone composition within the United States
.
J Endourol
.
2018
;
32
(
10
):
973
7
.
10.
Bobulescu
,
IA
,
Maalouf
NM
,
Capolongo
G
,
Adams-Huet
B
,
Rosenthal
TR
,
Moe
OW
, et al.
Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes
.
Am J Physiol Renal Physiol
.
2013
;
305
(
10
):
F1498
503
.
11.
Strohmaier
WL
,
Wrobel
BM
,
Schubert
G
.
Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis
.
Urol Res
.
2012
;
40
(
2
):
171
5
.
12.
Wrobel
BM
,
Schubert
G
,
Hörmann
M
,
Strohmaier
WL
.
Overweight and obesity: risk factors in calcium oxalate stone disease?
Adv Urol
.
2012
;
2012
:
438707
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.